These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 30714528)

  • 41. Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China.
    Wang Z; Zhang M; Zhang R; Liu L; Shen Y; Wang J; Lu H
    BMC Infect Dis; 2019 Apr; 19(1):313. PubMed ID: 30961560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The biological characteristics of predominant strains of HIV-1 genotype: modeling of HIV-1 infection among men who have sex with men.
    Dai D; Shang H; Han XX; Zhao B; Liu J; Ding HB; Xu JJ; Chu ZX
    J Med Virol; 2015 Apr; 87(4):557-68. PubMed ID: 25655808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil.
    Ferreira AS; Cardoso LP; Stefani MM
    J Med Virol; 2011 Aug; 83(8):1301-7. PubMed ID: 21678433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq.
    Dudley DM; Bailey AL; Mehta SH; Hughes AL; Kirk GD; Westergaard RP; O'Connor DH
    Retrovirology; 2014 Dec; 11():122. PubMed ID: 25533166
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug resistance and influencing factors in HIV-1-infected individuals under antiretroviral therapy in Guangxi, China.
    Pang X; He Q; Tang K; Huang J; Fang N; Xie H; Ma J; Zhu Q; Lan G; Liang S
    J Antimicrob Chemother; 2024 May; 79(5):1142-1152. PubMed ID: 38551451
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of CRF01_AE-specific polymorphic mutations G335D and A371V in the connection subdomain of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) on susceptibility to nucleoside RT inhibitors.
    Tanuma J; Hachiya A; Ishigaki K; Gatanaga H; Lien TT; Hien ND; Kinh NV; Kaku M; Oka S
    Microbes Infect; 2010 Dec; 12(14-15):1170-7. PubMed ID: 20713171
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of Drug Resistance and Genetic Transmission Networks Among Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Patients with Antiretroviral Therapy Failure in Guangxi, China.
    Yu D; Liang B; Yang Y; Liu J; Liang H; Zhang F; Jiang J; Huang J; Zhong S; Qin C; Jiang J; Liang H; Ye L
    AIDS Res Hum Retroviruses; 2022 Oct; 38(10):822-830. PubMed ID: 35972723
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of HIV type 1 genotypes and drug resistance mutations among drug-naive HIV type 1-infected patients in Northern Vietnam.
    Phan TT; Ishizaki A; Phung DC; Bi X; Oka S; Ichimura H
    AIDS Res Hum Retroviruses; 2010 Feb; 26(2):233-5. PubMed ID: 20156106
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the World Health Organization guidelines.
    Kebe K; Thiam M; Diagne Gueye NR; Diop H; Dia A; Signate Sy H; Charpentier C; Belec L; Mboup S; Toure Kane C
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):242-9. PubMed ID: 22860571
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular Characterization of the Human Immunodeficiency Virus Type 1 in Women and Their Vertically Infected Children.
    Vaz SN; Giovanetti M; Rego FF; Oliveira Td; Danaviah S; Gonçalves ML; Alcantara LC; Brites C
    AIDS Res Hum Retroviruses; 2015 Oct; 31(10):1046-51. PubMed ID: 26200738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 2018-2019 Update on the Molecular Epidemiology of HIV-1 in Indonesia.
    Khairunisa SQ; Megasari NLA; Ueda S; Budiman W; Kotaki T; Nasronudin ; Kameoka M
    AIDS Res Hum Retroviruses; 2020 Nov; 36(11):957-963. PubMed ID: 32799643
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HIV type 1 subtype C drug resistance among pediatric and adult South African patients failing antiretroviral therapy.
    Pillay V; Pillay C; Kantor R; Venter F; Levin L; Morris L
    AIDS Res Hum Retroviruses; 2008 Nov; 24(11):1449-54. PubMed ID: 19000027
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a cost-effective assay for genotyping of HIV-1 non-B subtype for drug resistance.
    Ammaranond P; Sanguansittianant S; Raju PA; Cunningham P; Horthongkham N
    J Virol Methods; 2014 Apr; 199():102-7. PubMed ID: 24462843
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.
    Aulicino PC; Rocco CA; Mecikovsky D; Bologna R; Mangano A; Sen L
    Antivir Ther; 2010; 15(4):641-50. PubMed ID: 20587857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.
    Couto-Fernandez JC; Silva-de-Jesus C; Veloso VG; Rachid M; Gracie RS; Chequer-Fernandez SL; Oliveira SM; Arakaki-Sanchez D; Chequer PJ; Morgado MG
    Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):73-8. PubMed ID: 15867968
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Major Drug Resistance Mutations on Reverse Transcriptase Gene in Human Immunodeficiency Virus Type-1 in Indonesia: A Systematic Review.
    Nurjannah ; Jayanti S; Tanoerahardjo FS; Al Musyahadah US; Sukowati CHC; Massi MN
    Curr HIV/AIDS Rep; 2024 Apr; 21(2):31-39. PubMed ID: 38244171
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sustained appearance of drug resistance-associated mutations in HIV-1 CRF01_AE protease and reverse transcriptase derived from protease inhibitor-naive Thai patients.
    Jullaksorn D; Boonchawalit S; Uttiyoung J; Soonthornsata B; Yowang A; Krathong N; Chautrakul S; Ikuta K; Roobsoong A; Kanitvittaya S; Sawanpanyalert P; Kameoka M
    Southeast Asian J Trop Med Public Health; 2010 Mar; 41(2):347-57. PubMed ID: 20578518
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary antiretroviral drug resistance among HIV type 1-infected individuals in Brazil.
    Sprinz E; Netto EM; Patelli M; Lima JS; Furtado JJ; da Eira M; Zajdenverg R; Madruga JV; Lewi DS; Machado AA; Pedro RJ; Soares MA
    AIDS Res Hum Retroviruses; 2009 Sep; 25(9):861-7. PubMed ID: 19689190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Analysis of virus gene subtypes and drug resistance monitoring results of newly reported HIV/AIDS population in Anhui Province from 2020 to 2023].
    Qin YZ; Shen YL; Liu AW; Wu JJ; Miu LF; Fang Q; Shuai CX; Jin L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Aug; 58(8):1204-1212. PubMed ID: 39142890
    [No Abstract]   [Full Text] [Related]  

  • 60. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
    Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
    Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.